NPI registry status
Active
2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1306845748
Verify on CMS → Natasa Janicic-Kahric
Endocrinology, Diabetes & Metabolism Physician in Washington, District of Columbia.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 217 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
51%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
76.6/100
▼ 7 pts below national avg 83.5 · Above neutral
Industry payments
$8.9K
11 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Natasa Janicic-Kahric reported a CMS MIPS final score of 76.6/100 - below the 83.5 national average - and filed 1,863 Medicare Part D claims in 2023.
- 76.6/100
- MIPS score · -7 vs avg
- 2K
- Part D claims, 2023
- 51%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Natasa Janicic-Kahric's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
77 ≥ 17th percentile 17% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Natasa Janicic-Kahric sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Natasa Janicic-Kahric writes more Part D claims than 42% of them and scores higher on MIPS quality than 19% - placing this provider in the lower-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Natasa Janicic-Kahric. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Natasa Janicic-Kahric practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Natasa Janicic-Kahric?
Below national averagePrimary specialty
Endocrinology, Diabetes & Metabolism Physician
Medicare Part D claims
1,863 29% vs specialty avg
MIPS final score
76.6/100 6.9 pts vs avg
Specialty distribution in District of Columbia
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among District of Columbia providers
Medicare quality performance, MIPS
Natasa Janicic-Kahric's 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 76.6/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Natasa Janicic-Kahric appears in the CMS NPPES registry as an Endocrinology, Diabetes & Metabolism Physician provider at 3800 RESERVOIR RD NW, Washington, DC, 20007, with a listed phone of (202) 444-2818. NPI 1306845748 was issued on 07/19/2005.
Medicare Part D records for calendar year 2023 show 1,863 prescription claims written by this provider, covering 217 Medicare beneficiaries and totaling roughly $884K in drug spend, split 42% brand-name and 51% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 76.6/100 for the 2023 performance year (Quality 63.2, Cost 55.9), compared with the 83.5 average among clinicians with a measured score.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,871 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1306845748 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Gender | Female |
| NPI Issued | 07/19/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
76.555
Final Score
Measured-score avg: 83.5
63.1616
Quality
55.9413
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Natasa Janicic-Kahric bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Medstar Medical Group II LLC
Washington, DC
Mgmc LLC
Washington, DC
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Natasa Janicic-Kahric. Source: openpaymentsdata.cms.gov.
Total received
$8.9K
Largest payer
Novo Nordisk Inc
Most common payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Natasa Janicic-Kahric - brand share 42.0%
Endocrinology, Diabetes & Metabolism Physician average
42% brand-name claims vs 51% generic, on 1,863 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,863
Total Claims
$884K
Total Drug Cost
217
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,489
- Total Day Supply
- 133,711
- Brand vs Generic
- 42% brand / 51% generic
- Brand Drug Cost
- $818K
- Generic Drug Cost
- $34K
Patient Demographics
- Average Patient Age
- 69.7 years
- Avg HCC Risk Score
- 1.77
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 36, 65-74: 115, 75-84: 54, 85+: 12
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Natasa Janicic-Kahric prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
191 claims
- Metformin Hcl
Metformin Hcl
131 claims
- Ozempic
Ozempic
102 claims
- Atorvastatin Calcium
Atorvastatin Calcium
82 claims
- Glimepiride 67
Glimepiride
67 claims
- Jardiance 60
Jardiance
60 claims
- Novolog Flexpen 57
Novolog Flexpen
57 claims
- Lisinopril 51
Lisinopril
51 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 191 |
| Metformin Hcl | 131 |
| Ozempic Semaglutide | 102 |
| Atorvastatin Calcium | 82 |
| Glimepiride | 67 |
| Jardiance Empagliflozin | 60 |
| Novolog Flexpen Insulin Aspart | 57 |
| Lisinopril | 51 |
| Alendronate Sodium | 49 |
| Trulicity Dulaglutide | 47 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Endocrinology, Diabetes & Metabolism Physician in DC →
All providers in District of Columbia →
Compare specialties →
Endocrinology, Diabetes & Metabolism Physician Overview
How Natasa Janicic-Kahric fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
7,871
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider
Natasa Janicic-Kahric's 1,863 claims are below the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in District of Columbia
Other clinicians with the same primary specialty enrolled in District of Columbia, drawn from the same CMS NPPES roster as Janicic-Kahric.
One of 45 Endocrinology, Diabetes & Metabolism Physician providers enrolled in District of Columbia, 5 are shown here.
Dr. Suzanne Adler
M.D.
Washington, DC
Dr. Chelsey Baldwin
MD
Washington, DC
Dr. Neelam Baral
MBBS
Washington, DC
Dr. Marc Blackman
M.D.
Washington, DC
Dr. Michael Bryan
M.D.
Washington, DC
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the District of Columbia medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore District of Columbia
Frequently Asked Questions
What is Natasa Janicic-Kahric's specialty? ▼
Natasa Janicic-Kahric specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Washington, District of Columbia.
How much does Natasa Janicic-Kahric prescribe under Medicare Part D? ▼
In 2023, Natasa Janicic-Kahric wrote 1,863 Medicare Part D claims totaling $884K in drug costs for 217 beneficiaries.
What is Natasa Janicic-Kahric's Medicare quality score? ▼
Natasa Janicic-Kahric has a CMS MIPS Final Score of 76.6/100 (Quality: 63.2, Cost: 55.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Natasa Janicic-Kahric located? ▼
Natasa Janicic-Kahric is located at 3800 RESERVOIR RD NW, Washington, DC, 20007. Phone: (202) 444-2818.
What is Natasa Janicic-Kahric's NPI number? ▼
Natasa Janicic-Kahric's National Provider Identifier (NPI) is 1306845748, issued on 07/19/2005.
Does Natasa Janicic-Kahric prescribe more brand-name or generic drugs? ▼
Natasa Janicic-Kahric's prescribing is 42% brand-name and 51% generic drugs by claim count, with $818K in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,871 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Natasa Janicic-Kahric prescribe most often? ▼
Based on 2023 Medicare Part D data, Natasa Janicic-Kahric's most frequently prescribed drugs include Levothyroxine Sodium, Metformin Hcl, Ozempic. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Natasa Janicic-Kahric accept Medicare? ▼
Natasa Janicic-Kahric appears in CMS Medicare data with 1,863 Part D claims and 217 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Natasa Janicic-Kahric's credentials? ▼
Natasa Janicic-Kahric's NPI is 1306845748. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.